Identifizierung kinematischer Variablen spezifisch für Patellarsehnenentzündung bei gefährdeten Sportlern (TENVOL)
Identifikation kinematischer Variablen spezifisch für Patellarsehnenentzündung bei gefährdeten Athleten
This research aims to identify and monitor specific kinematic markers associated with patellar tendinopathy in athletes at risk. Using a markerless motion capture system, vertical jump tests will be analyzed to detect early biomechanical changes in the knees, hips, trunk, and ankles. By comparing injured participants, the study seeks to improve early diagnosis and personalized prevention strategies for patellar tendinopathy.
Studienübersicht
Status
Status
Bedingungen
Bedingungen
Intervention / Behandlung
Intervention / Behandlung
- Diagnosetest: The intervention consists of a series of vertical jump tests captured using high-resolution cameras with markerless motion capture technology.
- Diagnosetest: The intervention consists of a series of vertical jump tests captured using high-resolution cameras with markerless motion capture technology at 6 months and 12 months
Detaillierte Beschreibung
Patellar tendinopathy, also known as Jumper's knee, is the most common pathology in elite sports, with 30% of diagnoses occurring in volleyball. Among elite volleyball players, the prevalence of this overuse-related condition ranges between 40% and 50%, resulting in anterior knee pain during daily and recreational activities, which can lead to deficits in strength and sports performance. To date, investigator can determine whether a patient has had a history of tendinopathy through modifications in biomechanical jump-landing strategies. However, there is a lack of early biomechanical markers to identify the onset of patellar tendinopathy and thus prevent its chronic progression. A preventive strategy using markerless motion capture technology, providing quantitative and visual feedback of a 3D human body model, shows promise. Investigators hypothesize that jump-landing kinematic analysis using markerless technology could identify early kinematic markers specific to patellar tendinopathy, distinguishing affected individuals from a non-tendinopathy population. This could ultimately help identify motor strategies following the onset of patellar tendinopathy A prospective longitudinal multicenter cohort. After signing the consent form, participants will undergo a medical examination, including a clinical assessment, a SLDS test, a Doppler ultrasound of the patellar tendon, and evaluation using the VISA-PF and OSTRC-P scores. Following a standardized 10-minute warm-up, participants will perform vertical jump tests captured by high-resolution cameras, analyzed using markerless motion capture technology. These assessments will be conducted at inclusion and at 3, 6, 9, and 12 months. Additional medical visits will occur if symptoms arise outside of testing.
Studientyp
Studientyp
Einschreibung (Geschätzt)
Einschreibung
Phase
Phase
- Unzutreffend
Kontakte und Standorte
Studienkontakt
Studienkontakt
- Name: Benjamin BEN ZAKI
- Telefonnummer: +336 66 09 13 43
- E-Mail: b-benzaki@chu-montpellier.fr
Studienorte
-
-
-
Montpellier, Frankreich
- Rekrutierung
- Sports Medicine and Traumatology LAPEYRONIE Hospital - Montpellier University Hospital
-
Kontakt:
- Benjamin BEN ZAKI
- Telefonnummer: +336 66 09 13 43
- E-Mail: b-benzaki@chu-montpellier.fr
-
-
Teilnahmekriterien
Zulassungskriterien
Zulassungskriterien
Studienberechtigtes Alter
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Beschreibung
- Subject aged between 18 and 45 years
- Male subject
- Regularly participating in physical activity involving jumping (a predisposing factor for patellar tendinopathy) twice a week for at least one year.
- Participants affiliated with or covered by a social security scheme
SPECIFIC INCLUSION CRITERIA FOR THE PATELLAR TENDINOPATHY GROUP
Patients with at least 2 of the following 3 criteria:
- Modified Öhberg score ≥2 according to L Öhberg, H Alfredson (2002)
- VISA-PF < 80/100 according to Kaux et al. (2016) and/or OSTRC P ≥ 6/100 according to Owoeye et al. (2018)
- Single Leg Decline Squat (SLDS): VAS ≥ 1/10 with pain mapping at the patellar tendon; according to Coombes et al. (2020)
SPECIFIC INCLUSION CRITERIA FOR THE HEALTHY GROUP
Patients with 0 or 1 of the following 3 criteria:
- Modified Öhberg score ≥2 according to L Öhberg, H Alfredson (2002)
- VISA-PF < 80/100 according to Kaux et al. (2016) and/or OSTRC P ≥ 6/100 according to Owoeye et al. (2018)
- Single Leg Decline Squat (SLDS): VAS ≥ 1/10 with pain mapping at the patellar tendon; according to Coombes et al. (2020)
Non inclusion Criteria:
- Significant medical and surgical history involving the lower limbs (e.g., ACL ligament reconstruction, meniscectomy, etc.)
- Contraindications to participating in sports activities
- Other pathologies involving the lower limbs (< 6 months), e.g., torn knee ligaments, ankle sprain, knee sprain, etc.
- Participants who have not given their informed consent
- Participants subject to legal protection measures (legal guardianship, conservatorship, curatorship)
- Participants deprived of their liberty by judicial or administrative decision
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Verhütung
- Zuteilung: Nicht randomisiert
- Interventionsmodell: Parallele Zuordnung
- Maskierung: Keine (Offenes Etikett)
Anzahl der Arme
Waffen und Interventionen
Teilnehmergruppe / ArmTeilnehmergruppe / Arm |
Intervention / BehandlungIntervention / Behandlung |
|---|---|
|
Experimental: patellar tendinopathy group
Diagnostic Test: The intervention consists of a series of vertical jump tests captured using high-resolution cameras with markerless motion capture technology. |
Participants will undergo clinical evaluations including the Single Leg Decline Squat (SLDS) test, VISA-PF, OSTRC-P questionnaires, and Doppler ultrasound of the patellar tendon. These assessments will take place at baseline (T0) and follow-up periods (M3, M6, M9, M12) to track the evolution of kinematic markers and clinical symptoms related to patellar tendinopathy. |
|
Sonstiges: healthy group
Diagnostic Test: The intervention consists of a series of vertical jump tests captured using high-resolution cameras with markerless motion capture technology. |
Participants will undergo clinical evaluations including the Single Leg Decline Squat (SLDS) test, VISA-PF, OSTRC-P questionnaires, and Doppler ultrasound of the patellar tendon. These assessments will take place at baseline (T0) and follow-up periods ( M6 et M12) to track the evolution of kinematic markers and clinical symptoms related to patellar tendinopathy. |
Was misst die Studie?
Primäre Ergebnismessungen
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Variations of knee flexion angle at initial contact at 3 months (only for patients in the patellar tendinopathy group)
Zeitfenster: Between the initial visit and the 3-month visit
|
The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology. |
Between the initial visit and the 3-month visit
|
|
Variations of knee flexion angle at initial contact at 6 months
Zeitfenster: Between the 3-month visit and the 6-month visit
|
The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology. |
Between the 3-month visit and the 6-month visit
|
|
Variations of knee flexion angle at initial contact at 9 months (only for patients in the patellar tendinopathy group)
Zeitfenster: Between the 6-month visit and the 9-month visit
|
The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology. |
Between the 6-month visit and the 9-month visit
|
|
Variations of knee flexion angle at initial contact at 12 months
Zeitfenster: Between the 9-month visit and the 12-month visit
|
The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology. |
Between the 9-month visit and the 12-month visit
|
|
Variations of the maximum knee flexion angle at 3 months (only for patients in the patellar tendinopathy group)
Zeitfenster: Between the initial visit and the 3-month visit
|
The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology. |
Between the initial visit and the 3-month visit
|
|
Variations of the maximum knee flexion angle at 6 months
Zeitfenster: Between the 3-month visit and the 6-month visit
|
The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology. |
Between the 3-month visit and the 6-month visit
|
|
Variations of the maximum knee flexion angle at 9 months (only for patients in the patellar tendinopathy group)
Zeitfenster: Between the 6-month visit and the 9-month visit
|
The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology. |
Between the 6-month visit and the 9-month visit
|
|
Variations of the maximum knee flexion angle at 12 months
Zeitfenster: Between the 9-month visit and the 12-month visit
|
The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology. |
Between the 9-month visit and the 12-month visit
|
|
Variations of the range of motion (ROM) of the knee between initial contact and maximum flexion angle at 3 months (only for patients in the patellar tendinopathy group)
Zeitfenster: Between the initial visit and the 3-month visit
|
The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology. |
Between the initial visit and the 3-month visit
|
|
Variations of the range of motion (ROM) of the knee between initial contact and maximum flexion angle at 6 months
Zeitfenster: Between the 3-month visit and the 6-month visit
|
The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology. |
Between the 3-month visit and the 6-month visit
|
|
Variations of the range of motion (ROM) of the knee between initial contact and maximum flexion angle at 9 months (only for patients in the patellar tendinopathy group)
Zeitfenster: Between the 6-month visit and the 9-month visit
|
The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology. |
Between the 6-month visit and the 9-month visit
|
|
Variations of the range of motion (ROM) of the knee between initial contact and maximum flexion angle at 12 months
Zeitfenster: Between the 9-month visit and the 12-month visit
|
The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology. |
Between the 9-month visit and the 12-month visit
|
|
Variations of the angle at the peak of the vertical ground reaction force (VGRF) at 3 months (only for patients in the patellar tendinopathy group)
Zeitfenster: Between the initial visit and the 3-month visit
|
The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology. |
Between the initial visit and the 3-month visit
|
|
Variations of the angle at the peak of the vertical ground reaction force (VGRF)at 6 months
Zeitfenster: Between the 3-month visit and the 6-month visit
|
The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology. |
Between the 3-month visit and the 6-month visit
|
|
Variations of the angle at the peak of the vertical ground reaction force (VGRF) at 9 months (only for patients in the patellar tendinopathy group)
Zeitfenster: Between the 6-month visit and the 9-month visit
|
The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology. |
Between the 6-month visit and the 9-month visit
|
|
Variations of the angle at the peak of the vertical ground reaction force (VGRF) at 12 months
Zeitfenster: Between the 9-month visit and the 12-month visit
|
The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology. |
Between the 9-month visit and the 12-month visit
|
|
Comparison of variation between healthy group and patellar tendinopathy group of knee flexion angle at initial contact at 6 months
Zeitfenster: Between the two 6-month visits of the two groups
|
The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology. |
Between the two 6-month visits of the two groups
|
|
Comparison between the healthy group and the patellar tendinopathy group of variation of the maximum knee flexion angle at 6 months
Zeitfenster: Between the two 6-month visits of the two groups
|
The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology. |
Between the two 6-month visits of the two groups
|
|
Comparison between the healthy group and the patellar tendinopathy group of variations of the range of motion (ROM) of the knee between initial contact and maximum flexion angle at 6 months
Zeitfenster: Between the two 6-month visits of the two groups
|
The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology. |
Between the two 6-month visits of the two groups
|
|
Comparison between the healthy group and the patellar tendinopathy group of variations of the angle at the peak of the vertical ground reaction force (VGRF)at 6 months
Zeitfenster: Between the two 6-month visits of the two groups
|
The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology. |
Between the two 6-month visits of the two groups
|
Sekundäre Ergebnismessungen
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Variations of the angle of flexion of the trunk, hips, knees, and ankles at initial contact at 3 months (only for patients in the patellar tendinopathy group)
Zeitfenster: Between the initial visit and the 3-month visit
|
The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology. |
Between the initial visit and the 3-month visit
|
|
Variations of the angle of flexion of the trunk, hips, knees, and ankles at initial contact at 6 months
Zeitfenster: Between the 3-month visit and the 6-month visit
|
The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology. |
Between the 3-month visit and the 6-month visit
|
|
Variations of the angle of flexion of the trunk, hips, knees, and ankles at initial contact at 9 months (only for patients in the patellar tendinopathy group)
Zeitfenster: Between the 6-month visit and the 9-month visit
|
The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology. |
Between the 6-month visit and the 9-month visit
|
|
Variations of the angle of flexion of the trunk, hips, knees, and ankles at initial contact at 12 months
Zeitfenster: Between the 9-month visit and the 12-month visit
|
The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology. |
Between the 9-month visit and the 12-month visit
|
|
Variations of the maximum flexion angle of the trunk, hips, knees, and ankles upon landing at 3 months (only for patients in the patellar tendinopathy group)
Zeitfenster: Between the initial visit and the 3-month visit
|
The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology. |
Between the initial visit and the 3-month visit
|
|
Variations of the maximum flexion angle of the trunk, hips, knees, and ankles upon landing at 6 months
Zeitfenster: Between the 3-month visit and the 6-month visit
|
The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology. |
Between the 3-month visit and the 6-month visit
|
|
Variations of the maximum flexion angle of the trunk, hips, knees, and ankles upon landing at 9 months (only for patients in the patellar tendinopathy group)
Zeitfenster: Between the 6-month visit and the 9-month visit
|
The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology. |
Between the 6-month visit and the 9-month visit
|
|
Variations of the maximum flexion angle of the trunk, hips, knees, and ankles upon landing at 12 months
Zeitfenster: Between the 9-month visit and the 12-month visit
|
The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology. |
Between the 9-month visit and the 12-month visit
|
|
Variations of the range of motion (ROM) of the trunk, hips, knees, and ankles between initial contact and maximum flexion angle upon landing at 3 months (only for patients in the patellar tendinopathy group)
Zeitfenster: Between the initial visit and the 3-month visit
|
The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology. |
Between the initial visit and the 3-month visit
|
|
Variations of the range of motion (ROM) of the trunk, hips, knees, and ankles between initial contact and maximum flexion angle upon landing at 6 months
Zeitfenster: Between the 3-month visit and the 6-month visit
|
The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology. |
Between the 3-month visit and the 6-month visit
|
|
Variations of the range of motion (ROM) of the trunk, hips, knees, and ankles between initial contact and maximum flexion angle upon landing at 9 months (only for patients in the patellar tendinopathy group)
Zeitfenster: Between the 6-month visit and the 9-month visit
|
The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology. |
Between the 6-month visit and the 9-month visit
|
|
Variations of the range of motion (ROM) of the trunk, hips, knees, and ankles between initial contact and maximum flexion angle upon landing at 12 months
Zeitfenster: Between the 9-month visit and the 12-month visit
|
The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology. |
Between the 9-month visit and the 12-month visit
|
|
Variations of the angle at the peak of the vertical ground reaction force (VGRF) of the hips, knees, and ankles upon landing at 3 months (only for patients in the patellar tendinopathy group)
Zeitfenster: Between the initial visit and the 3-month visit
|
The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology. |
Between the initial visit and the 3-month visit
|
|
Variations of the angle at the peak of the vertical ground reaction force (VGRF) of the hips, knees, and ankles upon landing at 6 months
Zeitfenster: Between the 3-month visit and the 6-month visit
|
The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology. |
Between the 3-month visit and the 6-month visit
|
|
Variations of the angle at the peak of the vertical ground reaction force (VGRF) of the hips, knees, and ankles upon landing at 9 months (only for patients in the patellar tendinopathy group)
Zeitfenster: Between the 6-month visit and the 9-month visit
|
The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology. |
Between the 6-month visit and the 9-month visit
|
|
Variations of the angle at the peak of the vertical ground reaction force (VGRF) of the hips, knees, and ankles upon landing at 12 months
Zeitfenster: Between the 9-month visit and the 12-month visit
|
The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology. |
Between the 9-month visit and the 12-month visit
|
Mitarbeiter und Ermittler
Sponsor
Sponsor
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Tatsächlich)
Studienbeginn
Primärer Abschluss (Geschätzt)
Primärer Abschluss
Studienabschluss (Geschätzt)
Studienabschluss
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Tatsächlich)
Zuerst gepostet
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes Update gepostet
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Zusätzliche relevante MeSH-Bedingungen
Andere Studien-ID-Nummern
Andere Studien-ID-Nummern
- RECHMPL25_0117
- 2025-A01948-41 (Registrierungskennung: IdRCB)
Plan für individuelle Teilnehmerdaten (IPD)
Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .